两种不同药物组成方案根除幽门螺杆菌的疗效及费用评估被引量：5

导出

摘要目的:评价两种不同药物组成方案根除幽门螺杆菌(Hp)的疗效及费用。方法:120例经内镜确诊为消化性溃疡、慢性胃炎,并14C呼气试验阳性患者随机分为2组,A组采用质子泵抑制剂(PPI)+四环素+呋喃唑酮+阿莫西林,B组用标准四联疗法PPI+果胶铋+阿莫西林+克拉霉素;两组治疗14 d,治疗结束4周后复查14C尿素呼气试验,比较治疗效果及治疗费用。结果:A组与B组Hp根除率分别为91.67%(55/60)和90%(54/60),差异无显著意义(P>0.05);A组与B组药品费用分别为136.40元和342.36元,差异有显著意义(P<0.01)。结论:PPI联合四环素、呋喃唑酮及阿莫西林根除清化道HP感染具有治疗效果好、费用低的优点。

作者陈晓琴王岚郑洲云周力

机构地区贵阳医学院附院消化科

出处《贵阳医学院学报》 CAS 2011年第6期630-631,共2页 Journal of Guiyang Medical College

关键词胃疾病治疗结果费用效益分析

分类号 R573 [医药卫生—消化系统]

引文网络
相关文献

参考文献5

1张健,童竞亚.幽门螺杆菌感染与胃部疾病[J].赣南医学院学报,2002,22(3):296-311. 被引量：1
2张林,王江滨.幽门螺杆菌根除治疗失败原因分析[J].中华消化杂志,2005,25(2):124-126. 被引量：99
3中华医学会消化病学分会幽门螺杆菌学组/幽门螺杆菌科研协作组.第三次全国幽门螺杆菌感染若干问题共识报告.胃肠病学,2008,:42-46.
4胡林,刘苓,周力.贵州省幽门螺杆菌临床菌株的分离培养与耐药分析.贵州省消化年会论文汇编,2010:59-60.
5陆英.奥美拉唑联合左氧氟沙星三联和四联疗法根除幽门螺杆菌的临床观察[J].贵州医药,2010,34(5):427-428. 被引量：6

二级参考文献74

1元刚,陈旻湖.幽门螺杆菌根除失败的补救措施[J].临床消化病杂志,2006,18(2):70-72. 被引量：31
2刘文忠.幽门螺杆菌感染与功能性消化不良[J].临床消化病杂志,2006,18(2):72-74. 被引量：50
3[2]Appelmelk BJ, Simoons -Smit I, Negrini R, et al. Potential role of molecular minicry between Helicobacter pylori lipopolysaccharide and hostLewis blood group antigens in autoimmunity[J].Infect Immun. 1996,64(6): 2031 - 2040.
4[3]Atherton JC,Cover TL,Twells RJ,et al. Simpleand accurate PCR based system for typing vacuolating cytotoxin alleles of Helicobacter pylori[J ].JClin Micro- biol. 1999,37(9) :2979 - 2982.
5[4]Azuma T, I to S, Satoo F, et al. The role of HLADQA1 gene in resistance to atrophic gastritis andgastric adenocarcinoma induced by Helicobacter pylori infection[J ]. Cancer, 1998,82(4): 1013 - 1018.
6[5]Blaser MJ, Not all Helicobacter pylori strain are created equal:Should al lbe eliminate[J ]. Lancet,1997,349( 9057):1020- 1022.
7[6]Blaser MS, Perez- Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strain possessing cag A is associated with an increased risk of developing adeno-carcinoma of the stomach[J]. Cancer Research. 1995, 55 ( 11 ): 2111 - 2115.
8[7]Boren T, Falk P, Roth KA, et al. Attachment of Helicobacter pylori tohumangastr epithelium mediated by blood group antigens[J]. Science, 1993, 262(5141 ): 1892 - 1895.
9[8]Censini S, Lange C, Xiag Z, etal. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated vir ulence factors[J ]. Proc Natl Acad Sci USA.1996,93: 14648 - 14653.
10[9]Churin Y, Kardalinen E, Meyer TF, and Nau-mann M. Pathogenicity island dependent activation of Rho GTPases Rac 1 and Cdc 42 in Helicobacter pylori infection [J]. Mol Microbiol.2001,40(4) :815 - 823.